用于胶质瘤脑血容量评估的速度选择性动脉自旋标记(VSASL):与基于VSASL的脑血流量及动态磁敏感对比增强MRI的比较
本研究纳入48例经病理证实的胶质瘤患者(平均年龄45±13岁,男性25例,低级别25例),术前接受VSASL-CBV MRI检查,由两名神经放射科医生对病灶显示清晰度进行视觉评分(1-3分),比较低级别与高级别胶质瘤的VSASL及DSC-PWI来源的相对肿瘤血容量(rTBV)和血流量(rTBF),并通过线性回归、Bland-Altman分析和ROC曲线评估相关性和诊断效能。结果显示VSASL-CBV图病灶显示清晰度良好(平均评分2.26±0.76,读者间加权κ=0.8),VSASL-rTBV与DSC-PWI-rTBV强相关(R²=0.83,p<0.001),两者均能显著区分低级别与高级别胶质瘤(p<0.001),VSASL-rTBV的AUC为0.94,优于VSASL-rTBF(AUC=0.89),与DSC-PWI-rTBV(AUC=0.93)相当。结论认为VSASL可提供准确、无创的CBV定量用于胶质瘤分层,诊断效能与DSC-PWI相当,在钆对比剂禁忌的临床场景中可作为替代选择。
要点
- VSASL-CBV图病灶显示清晰度良好,平均评分2.26±0.76,读者间加权κ=0.8。
- VSASL-rTBV与DSC-PWI-rTBV强相关(R²=0.83,p<0.001)。
- VSASL-rTBV鉴别胶质瘤分级的AUC为0.94,优于VSASL-rTBF(AUC=0.89),与DSC-PWI-rTBV(AUC=0.93)相当。
核心结论
- VSASL可提供准确、无创的CBV定量用于胶质瘤分层,诊断效能与DSC-PWI相当,在钆对比剂禁忌的临床场景中可作为替代选择。
研究设计与样本
- 前瞻性研究纳入48例经病理证实的胶质瘤患者(平均年龄45±13岁,男性25例,低级别25例),术前行VSASL-CBV MRI,由两名神经放射科医生对病灶显示清晰度进行视觉评分(1-3分),以DSC-PWI为参考比较VSASL来源的rTBV和rTBF。
关键影像表现/征象
- VSASL-CBV图病灶显示清晰度良好,平均评分2.26±0.76,读者间加权κ=0.8。
- VSASL-rTBV与DSC-PWI-rTBV强相关(R²=0.83,p<0.001)。
- VSASL和DSC-PWI指标均能显著区分低级别与高级别胶质瘤(p<0.001)。
诊断标准与关键数值
- VSASL-rTBV鉴别胶质瘤分级的AUC为0.94,优于VSASL-rTBF(AUC=0.89),与DSC-PWI-rTBV(AUC=0.93)相当。
- VSASL-rTBV的敏感度、预测值和准确率均优于VSASL-rTBF。
临床应用与阅片要点
- VSASL-CBV可用于无创评估胶质瘤血容量,在钆对比剂禁忌的临床场景中可作为DSC-PWI的替代选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Cerebral blood volume (CBV) maps created using dynamic susceptibility contrast-enhanced perfusion weighted imaging (DSC-PWI) are valuable but may be limited by gadolinium contraindications in certain clinical scenarios. A noninvasive perfusion method for CBV assessment based on velocity-selective (VS) ASL has emerged. This study is to evaluate the performance of VSASL-derived CBV among glioma patients in clinical practice, comparing with the VSASL-based cerebral blood flow (CBF) and DSC-PWI.
METHODS: Forty-eight patients with pathologically confirmed gliomas (mean age: 45 ± 13 years; 25 males; 25 in low-grade) underwent preoperative VSASL-CBV MRI. Lesion conspicuity on VSASL-CBV maps was visually scored (1-3) relative to surrounding parenchyma by two neuroradiologists. Relative maximum tumor blood volume (rTBV) and flow (rTBF) from VSASL and DSC-PWI were compared between low- and high-grade gliomas. Correlation and agreement between VSASL- and DSC-PWI-derived rTBV were assessed via linear regression and Bland-Altman analysis. Diagnostic performance for glioma grading was evaluated using ROC curves.
RESULTS: VSASL-CBV maps demonstrated good lesion conspicuity (mean score: 2.26 ± 0.76; inter-reader weighted κ = 0.8). VSASL-rTBV strongly correlated with DSC-PWI-rTBV (R²=0.83, p < 0.001). Both VSASL and DSC-PWI metrics significantly distinguished low- from high-grade gliomas (p < 0.001). ROC analysis revealed that VSASL-rTBV achieved excellent diagnostic accuracy in glioma grading (AUC = 0.94), outperforming VSASL-rTBF (AUC = 0.89) and matching DSC-PWI-rTBV (AUC = 0.93). Sensitivity, predictive values, and accuracy of VSASL-rTBV were superior to VSASL-rTBF.
CONCLUSION: VSASL provides accurate, noninvasive CBV quantification for glioma stratification, demonstrating diagnostic performance comparable to DSC-PWI. It offers a viable alternative in clinical settings where gadolinium contrast is contraindicated.
引用
- Qu Y, Ma A, Yan X, et al. Velocity-Selective arterial spin labeling (VSASL) for cerebral blood volume assessment in gliomas: comparison with VSASL based cerebral blood flow and dynamic susceptibility contrast MRI. Neuroradiology. 2025. PMID: 40892270. doi:10.1007/s00234-025-03751-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。